IMIPENEM AND CILASTATIN FOR INJECTION
IMIPENEM AND CILASTATIN FOR INJECTION
Discontinued
DIN Number
02357429
Drug Class
Human
Market Date
N/A
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02357429
AIG Number0218820002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DH51 IMIPENEM AND CILASTATIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.07.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
CILASTATIN (CILASTATIN SODIUM)Active
Strength: 250 MG
Monograph: CILASTATIN (CILASTATIN SODIUM)
IMIPENEMActive
Strength: 250 MG
Monograph: IMIPENEM